Dr Reddy's launches blood pressure drug chlorthalidone tablets in US mar
Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg
 "USFDA, drug maker, drugs, medicines")
Others like Lupin, too, see an opportunity in this
Dr Reddy's Laboratories Wednesday said it has launched chlorthalidone tablets, used to treat high blood pressure, in the US market.
Dr Reddy's Laboratories Ltd launched Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg, a therapeutic equivalent generic version of Hygroton tablets, Dr Reddy's Laboratories said in a BSE filing.
Quoting IMS Health data, Dr Reddy's Laboratories said, the Hygroton brand and its generic had US sales of approximately USD 122 million for the twelve months ending in September 2018.
Shares of Dr Reddy's were trading 1.14 per cent lower at Rs 2,560.60 apiece on the BSE.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 28 2018 | 11:20 AM IST